Clinical Trial Update: A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA [Phase 3]

View source ↗

Summary

Phase 3 randomized trial of fostamatinib disodium for warm autoimmune hemolytic anemia has completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Warm Antibody Autoimmune Hemolytic Anemia

Drugs mentioned

• Fostamatinib disodium (fostamatinib disodium)

Snippet

Sponsor: Rigel Pharmaceuticals | Conditions: Warm Antibody Autoimmune Hemolytic Anemia | Phase 3 | Status: COMPLETED | Results posted: 2023-05-25